New York, NY, United States of America

Raphaelle Berger



Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations by Raphaelle Berger

Introduction

Raphaelle Berger is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of fibrotic disorders. With a total of five patents to his name, Berger's work is recognized for its potential impact on various medical conditions.

Latest Patents

One of his latest patents is titled "Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fibrotic disorders." This invention provides methods for treating or preventing fibrotic diseases such as systemic sclerosis, cystic fibrosis, non-alcoholic steatohepatitis, Peyronie's disease, and interstitial lung disease. The method involves administering a therapeutically effective amount of a specific compound to patients in need of such therapy.

Another significant patent is "Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators." This invention presents certain fused pyrazine compounds that can modulate the body's production of cyclic guanosine monophosphate (cGMP). These compounds are suitable for the therapy and prophylaxis of diseases associated with a disturbed cGMP balance. The patent also includes pharmaceutical compositions that comprise these compounds and methods for their therapeutic use.

Career Highlights

Raphaelle Berger is currently employed at Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical industry. His work focuses on developing new treatments that can significantly improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Berger has collaborated with several talented individuals, including Subharekha Raghavan and Zhiqiang Yang. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Raphaelle Berger's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work has the potential to make a significant difference in the treatment of fibrotic disorders and other related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…